The safety of incretin based drugs | The BMJ

Important concerns have been raised about the impact of incretin based drugs on the risk of acute pancreatitis in patients with type 2 diabetes. Two linked papers by Li and colleagues (doi:10.1136/bmj.g2366) and Faillie and colleagues (doi:10.1136/bmj.g2780) could help us decide whether patients ...